These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8089882)

  • 1. Captopril, blood pressure, and diabetic nephropathy.
    Sawicki PT; Mühlhauser I; Berger M
    JAMA; 1994 Oct; 272(13):1005. PubMed ID: 8089882
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.
    Parving HH; Hommel E; Jensen BR; Hansen HP
    Kidney Int; 2001 Jul; 60(1):228-34. PubMed ID: 11422755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy.
    Insua A; Ribstein J; Mimran A
    Postgrad Med J; 1988; 64 Suppl 3():59-62; discussion 90-2. PubMed ID: 3074298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between the effect of glibenclamide and captopril on experimentally induced diabetic nephropathy in rats.
    Akbar DH; Hagras MM; Amin HA; Khorshid OA
    J Renin Angiotensin Aldosterone Syst; 2013 Jun; 14(2):103-15. PubMed ID: 23077081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Converting enzyme-inhibition in diabetic nephropathy.
    Mathiesen ER; Parving HH; Hommel E
    Contrib Nephrol; 1989; 73():160-1; discussion 161-2. PubMed ID: 2689092
    [No Abstract]   [Full Text] [Related]  

  • 6. Antihypertensives retarding progression of diabetic nephropathy.
    Hardy KJ
    Diabetologia; 1995 Jan; 38(1):123-4. PubMed ID: 7744219
    [No Abstract]   [Full Text] [Related]  

  • 7. Captopril and diabetic nephropathy.
    Lewis EJ
    JAMA; 1995 Jun; 273(23):1831. PubMed ID: 7776492
    [No Abstract]   [Full Text] [Related]  

  • 8. Captopril in diabetic nephropathy.
    Fong M; Hart LL
    DICP; 1990 Mar; 24(3):260-1. PubMed ID: 2180219
    [No Abstract]   [Full Text] [Related]  

  • 9. Captopril for diabetic nephropathy.
    Med Lett Drugs Ther; 1994 May; 36(923):46-7. PubMed ID: 8177138
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of captopril on heavy proteinuria in azotemic diabetics.
    Taguma Y; Kitamoto Y; Futaki G; Ueda H; Monma H; Ishizaki M; Takahashi H; Sekino H; Sasaki Y
    N Engl J Med; 1985 Dec; 313(26):1617-20. PubMed ID: 3906398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of blood pressure-reducing therapy with captopril on tubular marker excretion in type-1 diabetics with nephropathy].
    Ratzmann KP; Raskovic M; Schimke E
    Dtsch Med Wochenschr; 1994 Jun; 119(22):796-800. PubMed ID: 8205941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme inhibition in diabetic nephropathy. The Collaborative Study Group.
    Breyer JA; Hunsicker LG; Bain RP; Lewis EJ
    Kidney Int Suppl; 1994 Feb; 45():S156-60. PubMed ID: 8158886
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.
    Lewis EJ; Hunsicker LG; Bain RP; Rohde RD
    N Engl J Med; 1993 Nov; 329(20):1456-62. PubMed ID: 8413456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slowing the progression of diabetic nephropathy.
    Remuzzi G; Ruggenenti P
    N Engl J Med; 1993 Nov; 329(20):1496-7. PubMed ID: 8413463
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diabetic Nephropathy. Captopril can improve survival in hypertensive diabetics. Proceedings of a symposium at the IFECC III. Monte Carlo, January 1994].
    Internist (Berl); 1994 Apr; 35(4 Suppl):1-4. PubMed ID: 8188458
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.
    Fournier A; Lalau JD
    N Engl J Med; 1994 Mar; 330(13):937; author reply 938. PubMed ID: 8114873
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.
    Parving HH
    N Engl J Med; 1994 Mar; 330(13):937-8. PubMed ID: 8114875
    [No Abstract]   [Full Text] [Related]  

  • 18. Changing the course of diabetic nephropathy: angiotensin-converting enzyme inhibition in type I diabetic renal disease.
    Pohl MA
    Cleve Clin J Med; 1994; 61(1):38-42. PubMed ID: 8124846
    [No Abstract]   [Full Text] [Related]  

  • 19. Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
    Romanelli G; Giustina A; Cravarezza P; Caldonazzo A; Agabiti-Rosei E; Giustina G
    J Hum Hypertens; 1991 Jun; 5(3):167-73. PubMed ID: 1920340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of angiotensin converting enzyme inhibitors in the treatment of diabetic nephropathy].
    Romero R; Sanmartí A; Salinas I; Teixidó J; Foz M; Caralps A
    Med Clin (Barc); 1988 Mar; 90(12):494-6. PubMed ID: 3292854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.